scispace - formally typeset
A

Albert Bové

Researcher at University of Barcelona

Publications -  50
Citations -  3035

Albert Bové is an academic researcher from University of Barcelona. The author has contributed to research in topics: Antiphospholipid syndrome & Anti-nuclear antibody. The author has an hindex of 31, co-authored 50 publications receiving 2712 citations.

Papers
More filters
Journal ArticleDOI

Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.

TL;DR: The increasing number of reported cases of HBV reactivation following TNF-targeted therapies and the associated morbidity and mortality demand specific preventive strategies.
Journal ArticleDOI

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

TL;DR: 97% of cases of ILD associated with biologic agents were associated with agents blocking tumor necrosis factor-α, a cytokine that has been implicated in the pathophysiology of pulmonary fibrosis, and drug-induced ILD had a poor prognosis.
Journal ArticleDOI

Cutaneous vasculitis in primary Sjogren syndrome : classification and clinical significance of 52 patients

TL;DR: The main characteristics of SS-associated cutaneous Vasculitis were the overwhelming predominance of small versus medium vessel vasculitis and leukocytoclastic versus mononuclear vasculopathy, with a higher prevalence of extraglandular and immunologic SS features.
Journal ArticleDOI

Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.

TL;DR: The presence of vasculitis in patients with SLE was associated with a higher ECLAM score, livedo reticularis, hematologic parameters (anemia, high ESR), and anti-La/SS-B antibodies and nearly 60% of cases not fulfilling the names and definitions adopted by the Chapel Hill Consensus Conference.
Journal ArticleDOI

Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients:

TL;DR: It is concluded that patients with SLE have an increased overall risk for infection and they are especially prone to develop urinary infection, pneumonia and bacteraemia without focus.